Denosumab high ICER vs zolendronic acid in the US

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.655, 2012-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alendronic acid/denosumab interaction: Interaction (first report) leading to osteonecrosis of the jaw in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1310, 2010-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

The introduction of folic acid fortification in the US has led to a marked reduction in the number of high maternal serum -fetoprotein (AFP) levels

Inpharma, Vol. 1, Iss. 1438, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

ICER favours vinorelbine + cisplatin for NSCLC

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 534, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Healthcare administration costs huge in the US vs Canada

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 427, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Generic pamidronic acid approved in the US.

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite